U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07267273) titled 'Betamethasone Phonophoresis For Vitiligo' on Nov. 23.
Brief Summary: Vitiligo is a skin disorder that results in the formation of depigmented patches or hypopigmented macules due to selective destruction or reduction of melanocytes the cells that produce pigment in our skin.
Vitiligo affects 0.1-2% of the World's population. People of all skin types and all ages can be affecte. In most of the cases, white patches develop or expand slowly overtime, and in some cases it never progress and remains stable . Vitiligo can be segmental or non-segmental depending upon the morphology of the clinical involvement. It can also be classified as ...